search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Lasers & photonics


Mid-infrared QCL imaging has been explored for identifying tumour margins in breast tissue samples, which may have been flagged after a mammogram.


what are the things that we could measure well and very specifically with the terahertz,” says Faist. Manufacturing QCLs involves molecular beam


epitaxy, a process in which beams of atoms or molecules of specific elements are deposited on a surface. The process is extremely sensitive to material flaws, which limits production yields. Developing QCL-based devices therefore demands precise control over epitaxial growth, layer thickness and interface quality. This adds to the complexity of producing them and performing quality control, further increasing their costs.


The MILADO project, an international consortium of research institutions and companies in the field, is working to improve their manufacturability. Current QCL-based detection systems are bulky. The project aims to replace them with QCL arrays, which could be miniaturised, produced in large volumes and integrated like photonic chips. In the future, these could pack the diagnostic power of QCLs in a portable device or wearable, enabling commercial adoption in medical devices. QCLs can scan absorption spectra thousands of times per second, which allows them to take a very large number of measurements in that time. However, their spectral coverage is limited as individual QCLs typically sense absorption over a narrow wavelength range. Scientists are exploring ways to improve spectral coverage without sacrificing measurement speed. For instance, researchers at the Fraunhofer Institute for Applied Solid State Physics, one of the partners in the MILADO project, are developing multiplexed laser technology that couples spectrally adjacent modules together.


QCLs have been limited to laboratory-scale equipment because of their high power requirements and the large amounts of waste heat they produce. A push towards low-dissipation QCLs is critical to improving their portability. If these lasers can be made compact, energy-efficient and manufacturable


56


at scale, says Faist, they could then be integrated into a range of health-monitoring systems. Another exciting development, he adds, is QCL frequency combs, which emit light spanning multiple discrete, equally spaced frequencies like a comb spectrum. “With frequency combs, we could do infrared spectroscopy with much [fewer] moving parts,” says Faist.


A killer application


While there are dozens of companies manufacturing quantum cascade lasers, many of them focus on industrial and research markets, but mass-market consumer devices using them have not yet materialised. “There is a market for them,” says Capasso, “but it’s not a high-volume market because no one has found a killer application yet.” Could that change in the coming years? There is a growing demand for highly sensitive technologies for medical diagnostics as well as industrial and environmental sensing, and QCLs are well placed to meet that demand. Advances in manufacturing QCLs, new semiconductor materials, miniaturisation and effective cooling solutions will increase their value proposition. Low-cost production of miniaturised QCL-based devices at scale could lead to wider adoption of the technology, including in the medical device sector.


It took a long time for QCL technology to mature to its current status. But for any technology, notes Faist, “It also takes a long time to develop the whole ecosystem around it, and for people to learn to use those correctly.” This part can be even more challenging when the intended application is medical diagnostics.


“A sensor contains a laser source, a detector, other optical elements, a sampling space and a data analysis chain,” says Faist. “You need to put all those things together and validate them for medical use, and that is a very complex thing.” ●


www.medicaldevice-developments.com


Frame Stock Footage/Shutterstock.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100